• BP, cholesterol interventions yield ‘legacy' benefit in ASCOT trial follow-up

    11 days ago - By Healio

    MUNICH - Sixteen years of follow-up in the ASCOT Legacy trial show that antihypertensive treatment with a calcium channel blocker-based regimen and lipid lowering with a statin demonstrated long-term beneficial effects on mortality.
    Patients on amlodipine-based treatment had fewer stroke deaths and patients on atorvastatin had fewer CV deaths more than a decade after the trial was stopped.
    “This study is the first to report that both blood pressure and lipid-lowering treatments confer long-term cardiovascular mortality benefits,” Ajay K. Gupta, MD, of the William Harvey
    Read more ...